Safety and efficacy of fingolimod and natalizumab in multiple sclerosis after the failure of first-line therapy: Single center experience based on forty-four patients
Puz, P., Lasek-Bal, A.Том:
381
Мова:
english
Журнал:
Journal of the Neurological Sciences
DOI:
10.1016/j.jns.2017.08.3481
Date:
October, 2017
Файл:
PDF, 341 KB
english, 2017